Quick Takeaways
- ForGrowth III PA B.V. filed SCHEDULE 13G for Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO).
- Disclosed ownership: 6.1%.
- Date of event: 08 Dec 2025.
ForGrowth III PA B.V. - 08 Dec 2025 SCHEDULE 13G Report for Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO)
- Filing Manager
- ForGrowth III PA B.V.
- Reporting Manager
- ForGrowth III PA B.V.
- Symbol
- CBIO
- Shares outstanding
- 27,505,770 shares
- Disclosed Ownership
- 1,677,852 shares
- Ownership
- 6.1%
- Form type
- SCHEDULE 13G
- Filing time
- 11 Dec 2025, 16:00:02 UTC
- Date of event
- 08 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ForGrowth III PA B.V. disclosed 6.1% ownership in Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO) on 08 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 11 Dec 2025, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ForGrowth III PA B.V. | 6.1% | 1,677,852 | 0 | 1,677,852 | /s/ M.A. van Osch and /s/ G.J. Mulder | M.A. van Osch and G.J. Mulder, Directors of its Director | |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 6.1% | 1,677,852 | 0 | 1,677,852 | /s/ M.A. van Osch and /s/ G.J. Mulder | M.A. van Osch and G.J. Mulder, Directors of its Director | |
| Forbion Growth III Management B.V. | 6.1% | 1,677,852 | 0 | 1,677,852 | /s/ M.A. van Osch and /s/ G.J. Mulder | M.A. van Osch and G.J. Mulder, Directors |